Fangfang Mo

Dr. Fangfang Mo

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

11 September 2019 in Molecules
Verified
Journal Article
Open access
PDF file
YBYing Bai
Ying Bai
RZRuyuan Zhu
Ruyuan Zhu
YTYimiao Tian
Yimiao Tian
RLRui Li
Rui Li
BCBeibei Chen
Beibei Chen
SGSihua Gao
Sihua Gao
This review aimed to provide a general view of catalpol in protection against diabetes and diabetic complications, as well as its pharmacokinetics and safety concerns. The following databases were consulted with the retrieval of more than 100 publications through June 2019: PubMed, Chinese National Knowledge Infrastructure, WanFang Data, and web of science. Catalpol exerts an anti-diabetic effect in different animal models with an oral dosage ranging from 2.5 to 200 mg/kg in rats and 10 to 200 mg/kg in mice. Besides, catalpol may prevent the development of diabetic complications in kidney, heart, central nervous system, and bone. The underlying mechanism may be associated with an inhibition of inflammation, oxidative stress, and apoptosis through modulation of various cellular signaling, such as AMPK/PI3K/Akt, PPAR/ACC, JNK/NF-κB, and AGE/RAGE/NOX4 signaling pathways, as well as PKCγ and Cav-1 expression. The pharmacokinetic profile reveals that catalpol could pass the blood-brain barrier and has a potential to be orally administrated. Taken together, catalpol is a well-tolerated natural compound with promising pharmacological actions in protection against diabetes and diabetic complications via multi-targets, offering a novel scaffold for the development of anti-diabetic drug candidate. Further prospective and well-designed clinical trials will shed light on the potential of clinical usage of catalpol.

1 October 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
MLMeixi Lu
Meixi Lu
JYJiyuan Yin
Jiyuan Yin
TXTianshu Xu
Tianshu Xu
XDXuan Dai
Xuan Dai
LYliu tian yuan
liu tian yuan
DZDongwei Zhang
Dongwei Zhang

1 January 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
LLLin Li
Lin Li
HZHao Zhang
Hao Zhang
BCBeibei Chen
Beibei Chen
BXBingke Xia
Bingke Xia
RZRuyuan Zhu
Ruyuan Zhu
DZDongwei Zhang
Dongwei Zhang

1 October 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
BCBeibei Chen
Beibei Chen
JWJunping Wei
Junping Wei
RZRuyuan Zhu
Ruyuan Zhu
HZHao Zhang
Hao Zhang
BXBingke Xia
Bingke Xia
DZDongwei Zhang
Dongwei Zhang

Verified
Journal Article
Open access
PDF file
FMFangfang Mo
Fangfang Mo
BLBohan Lv
Bohan Lv
DZDandan Zhao
Dandan Zhao
ZXZiye Xi
Ziye Xi
YQYining Qian
Yining Qian
SGSihua Gao
Sihua Gao
MicroRNAs (miRNAs) and transfer RNA-derived small RNAs (tsRNAs) play critical roles in the regulation of different biological processes, but their underlying mechanisms in diabetes mellitus (DM) are still largely unknown. This study aimed to gain a better understanding of the functions of miRNAs and tsRNAs in the pathogenesis of DM. A high-fat diet (HFD) and streptozocin (STZ)-induced DM rat model was established. Pancreatic tissues were obtained for subsequent studies. The miRNA and tsRNA expression profiles in the DM and control groups were obtained by RNA sequencing and validated with quantitative reverse transcription-PCR (qRT-PCR). Subsequently, bioinformatics methods were used to predict target genes and the biological functions of differentially expressed miRNAs and tsRNAs. We identified 17 miRNAs and 28 tsRNAs that were significantly differentiated between the DM and control group. Subsequently, target genes were predicted for these altered miRNAs and tsRNAs, including Nalcn, Lpin2 and E2f3. These target genes were significantly enriched in localization as well as intracellular and protein binding. In addition, the results of KEGG analysis showed that the target genes were significantly enriched in the Wnt signaling pathway, insulin pathway, MAPK signaling pathway and Hippo signaling pathway. This study revealed the expression profiles of miRNAs and tsRNAs in the pancreas of a DM rat model using small RNA-Seq and predicted the target genes and associated pathways using bioinformatics analysis. Our findings provide a novel aspect in understanding the mechanisms of DM and identify potential targets for the diagnosis and treatment of DM.